bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.02.01.578391

In vitro antimicrobial activity of non-aureus Staphylococci and Mammaliicocci against Staphylococcus aureus and Streptococcus uberis and their relationship with the presence of intramammary infections in organic dairy cows

Pena Mosca, F.·Gaire, T. N.·Dean, C. J.·Manriquez, D.·Pinedo, P.·Noyes, N.·Caixeta, L. S.
View original source ↗Export metadata ↓

Abstract

Prior studies have suggested that non-aureus staphylococci and mammaliicoci (NASM) possess inhibitory activity against mastitis pathogens. However, their impact on udder health outcomes and the mechanisms underlying this potential protective effect remain poorly understood. Our first objective was to identify NASM species on teat apices of organic dairy cows, assess their within-species phylogeny, and explore associations with presence of intramammary infections (IMI) and genomic features, including antimicrobial peptides (AMPs), virulence, and resistance genes. The second objective was to evaluate the in vitro antimicrobial activity of NASM isolates against mastitis pathogens and examine its associations with taxonomy, phylogeny, AMP genes, and IMI. Milk and teat apex swabs were collected weekly from 114 cows on two organic farms. Milk was cultured to identify Staphylococcus aureus (SAU) or Streptococcus spp. and Streptococcus-like organisms (SSLO) IMI. A case-control was designed to include cows with and without SAU or SSLO IMI. For each selected cow, the teat apex gauze swab collected during the week preceding IMI diagnosis (or corresponding time for controls) was aerobically cultured, and the taxonomy of isolates was determined using mass spectrometry. Isolates classified as NASM were subjected to whole genome sequencing using Illumina MiSeq. The inhibitory activity of NASM isolates was tested against SAU and Streptococcus uberis. Phylogenetic trees were constructed using Snippy and IQ-TREE. Genomes were assembled and annotated to identify species, AMP genes, virulence, and antimicrobial resistance markers. The in vitro antimicrobial activity of NASM varied across species and between cows with and without an IMI. Staphylococcus succinus was the species most frequently associated with highly inhibitory isolates, which were more prevalent in cows without IMI (19.4% vs 5.8%). Organic dairy cow teat apices harbored multiple NASM species and strains. All isolates had at least 1 AMP associated gene in their genome. In vitro antimicrobial activity was generally unrelated to clade membership, except for isolates classified as Staphylococcus succinus. Staphylococcus aureus had high virulence gene prevalence, while NASM species showed lower, species-specific prevalence. This study advances understanding of NASM antimicrobial activity and virulence potential.

Source connections

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pena Mosca, F., Gaire, T. N., Dean, C. J., Manriquez, D., Pinedo, P., Noyes, N., Caixeta, L. S.. 2024-02-02. In vitro antimicrobial activity of non-aureus Staphylococci and Mammaliicocci against Staphylococcus aureus and Streptococcus uberis and their relationship with the presence of intramammary infections in organic dairy cows. https://doi.org/10.1101/2024.02.01.578391

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗
bioRxiv2026

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗
bioRxiv2026

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗